Do you have a question about interstitial lung disease? Daniel Culver, MD, Staff Physician, and Joseph Parambil, MD, Associate Staff, both of the Department of Pulmonary, Allergy and Critical Care Medicine, will answer your questions about this topic during a live webchat Wednesday, Nov. 7, 2012, at noon (ET).
Get answers to your health questions and concerns. It’s easy to be part of our live chat events, led by Cleveland Clinic doctors and health professionals.
Interstitial lung diseases (ILD) affect the tissue and space around the air sacs, and differ from obstructive airway diseases. The group includes illnesses caused by inhaled substances, medications, infection, disease, malignancy and unknown causes.
Causes of ILD include forms of pulmonary fibrosis and interstitial pneumonia, as well as exposure to environmental and occupational toxins. The scarring associated with ILD affects a person’s ability to breathe.
Although scarring is mostly irreversible, medication therapies can slow further progression of lung damage. Pulmonary treatments and oxygen therapy can provide relief to patients. In severe cases, surgery and lung transplants can be an option for some ILD patients.
Dr. Culver is a Staff Physician in the Department of Pulmonary, Allergy, and Critical Care Medicine at Cleveland Clinic’s main campus. His clinical interests include sarcoidosis, pulmonary alveolar proteinosis, critical care and interstitial lung diseases.
Dr. Parambil is an Associate Staff Member in the Department of Pulmonary, Allergy and Critical Care Medicine. He is also Assistant Professor of Medicine at Cleveland Clinic’s Lerner College of Medicine.
This health chat will open on Tuesday, Nov. 6, 2012 to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.